SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Safety of tiotropium: Indirect evidence suggests the Respimat inhaler is riskier than the Handihaler

Cates, CJ (2011) Safety of tiotropium: Indirect evidence suggests the Respimat inhaler is riskier than the Handihaler. BRITISH MEDICAL JOURNAL, 342. pp. 1-2. ISSN 0959-8138 https://doi.org/10.1136/bmj.d2970
SGUL Authors: Cates, Christopher Joseph

[img]
Preview
PDF Published Version
Available under License St George's repository terms & conditions.

Download (743kB) | Preview

Item Type: Article
Additional Information: PubMed ID: 21672998
Keywords: Bronchodilator Agents, Humans, Pulmonary Disease, Chronic Obstructive, Randomized Controlled Trials as Topic, Scopolamine Derivatives, Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: BRITISH MEDICAL JOURNAL
ISSN: 0959-8138
Related URLs:
Dates:
DateEvent
14 June 2011Published
Web of Science ID: WOS:000291932100001
URI: http://openaccess.sgul.ac.uk/id/eprint/2681
Publisher's version: https://doi.org/10.1136/bmj.d2970

Actions (login required)

Edit Item Edit Item